Form D · Biotechnology

CYLENE PHARMACEUTICALS, INC.

San Diego, CA · CIK 0001142536

Offering snapshot reported Jan 22, 2013 · SEC filing

Reported sold
$867K
Offering amount: $1M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 8, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 22, 2013Initial$867,000No comparison5SEC filing
Aug 11, 2011Amendment$15,635,924$9,492,415vs Jun 11, 201018SEC filing
Jun 11, 2010Initial$6,143,509No comparison17SEC filing
Jan 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-190595

Source: Form D, filed Jan 22, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Reinhard J. Ambros Director
Reinhard J. Ambros, Ph.D. Director
Peter Feinstein Director
Shaun A. Kirkpatrick Director
Fred A. Middleton Director
Erich Platzer Director
Erich Platzer, M.D. Director
William G. Rice Director, Executive
William G. Rice, Ph.D. Director, Executive
S. Edward Torres Director
Daniel D. Von Hoff Director
Daniel D. Von Hoff, M.D., F.A.C.P. Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5820 Nancy Ridge Drive, Suite 200
San Diego, CA, 92121